Steroid injections into myofascial trigger points versus joint injections for shoulder osteoarthritis
Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache
Run by Beijing Tiantan Hospital · NCT07347054 · Data updated 2026-11-12
This study will test whether steroid injections into muscle trigger points work as well as steroid injections into the shoulder joint for adults with shoulder osteoarthritis and ongoing shoulder pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 1036 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07347054 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45 or older with radiographic shoulder osteoarthritis (Kellgren-Lawrence grade 1–4), at least one myofascial trigger point, disease >3 months, and NRS pain ≥3 despite prior conservative treatment are the intended participants.
✕Probably not a fit
Patients with corticosteroid allergy, recent intra-articular injections, long-term systemic steroid use, significant comorbidities (severe organ dysfunction, inflammatory rheumatic disease), substance abuse, or other exclusion criteria are unlikely to benefit from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, controlled, blinded-outcome, non-inferiority trial comparing two injection approaches for shoulder osteoarthritis: glucocorticoid injection at myofascial trigger points (MTrPs) versus intra-articular (joint cavity) glucocorticoid injection. Eligible patients are randomized into one of the two treatment groups and receive the assigned injection, with standardized procedures and follow-up visits. Patients will be followed for two years with repeated measures of pain and function (for example, NRS and common osteoarthritis function scales) to compare long-term effects. The design focuses on whether MTrP injections can provide similar durable symptom relief while being easier to perform.
Why it matters
Potential benefit: If successful, patients could get similar long-term pain relief and improved shoulder function with a simpler, safer, and easier-to-deliver injection into trigger points instead of direct joint injection.
How similar studies have gone: Previous domestic and international reports have shown that glucocorticoid injections at myofascial trigger points can reduce pain short-term, but long-term data and head-to-head non-inferiority comparisons with intra-articular injections are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of shoulder osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point; * Disease duration exceeding 3 months; * Age ≥ 45 years; * Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment; * Signed informed consent form. Exclusion Criteria: * History of allergy to trial medications such as corticosteroids; * Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy; * Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.; * Intra-articular injection within the past 6 months or planned joint replacement surgery; * Inability to use pain assessment scales; * Presence of local or systemic infection; * Pregnant or lactating patients.
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: +86 13611326978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trigger-point steroid injections versus hip joint steroid injections for hip osteoarthritis
This test compares steroid injections into myofascial trigger points versus injections into the hip joint to see which reduces pain and improves function in people aged 45 and older with hip osteoarthritis.
-
Glucocorticoid injections into myofascial trigger points to treat knee osteoarthritis.
This study will test whether injecting corticosteroid into myofascial trigger points reduces pain and improves function for adults 45 and older with knee osteoarthritis.
-
vEAET-H: a virtual group emotional therapy for chronic pain patients using medical cannabis in Israel
This study tests a Hebrew, virtual, group-based emotional therapy to see if it can help reduce pain and improve emotional well-being in Israeli adults with chronic musculoskeletal pain who use medical cannabis.
-
Effects of Different Myofascial Release Techniques on Function in Chronic Neck Pain
This trial tests whether manual or self-applied myofascial release, in addition to standard therapy and exercise, can improve function and reduce pain in adults with chronic non-specific neck pain.
-
Ischemic Compression Plus Home Exercise for Non-Specific Neck Pain
This study tests whether adding ischemic compression to a home exercise program helps reduce neck pain and disability more than home exercise alone in adults with non-specific neck pain.
-
Steroid injection into neck muscle trigger points versus C2 dorsal root ganglion (nerve) block for chronic cervicogenic headache
This trial will test whether steroid injections into neck myofascial trigger points work as well as C2 dorsal root ganglion (nerve) blocks to reduce pain in adults with chronic cervicogenic headache.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.